David L. Grange is CEO at PHARMACEUTICAL PRODUCT DEVELOPMENT INC (PPDI). They have made 6 open-market trades across 1 company since 2006, most recently 2011-02-28.
CIK 0001264908
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 6 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| PPDI | 61,045 | — |
Shares reported on the most recent Form 4, priced at the 2011-03-01 close. 1 holding could not be priced and is excluded from the total.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| PPDI | SELL | 2011-02-28 | 2011-03-01 | $26.00 | $897K | N/A | N/A | N/A |
| PPDI | SELL | 2010-11-02 | 2010-11-04 | $25.71 | $1.3M | N/A | N/A | N/A |
| PPDI | SELL | 2008-08-07 | 2008-08-08 | $41.35 | $418K | N/A | N/A | N/A |
| PPDI | SELL | 2007-07-26 | 2007-07-27 | $33.77 | $184K | N/A | N/A | N/A |
| PPDI | SELL | 2007-02-09 | 2007-02-12 | $34.14 | $205K | N/A | N/A | N/A |
| PPDI | SELL | 2006-05-24 | 2006-05-24 | $36.24 | $362K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.